Kesmalea Therapeutics
London
About Kesmalea Therapeutics
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degrades. The company also provides an alternative approach for therapeutics with ‘PROTAC-like’ actions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $33.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: kesmalea.com
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/kesmalea-therapeutics-19137 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.